Mar 20 |
Billionaire Steve Cohen and Insiders Are Buying These 10 Stocks
|
Mar 18 |
Ozempic Can’t Do It All—A Potential New Blockbuster Is a Reminder of That
|
Mar 15 |
Madrigal (MDGL) Stock Up as FDA Approves First Drug for NASH
|
Mar 14 |
Ionis (IONS) Drug Meets Mid-Stage MASH Study Goals
|
Mar 8 |
Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
|
Mar 7 |
Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology
|
Mar 7 |
President and CEO Andrew Cheng Sells 75,000 Shares of Akero Therapeutics Inc (AKRO)
|
Mar 6 |
Akero Therapeutics announces pricing of stock offering to raise $319M
|
Mar 6 |
Akero Therapeutics Announces Pricing of Public Offering of Common Stock
|
Mar 5 |
Akero (AKRO) Up on Upbeat Week 96 Data From Liver Disease Study
|